Evidence map›Paper›PMID 31642990›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.

Hayley S Whitford, Pawel Kalinowski, Adrian Schembri, Peter Grimison, Martin Stockler, Andrew Martin, Guy C Toner, Ian D Davis, Paul Maruff, Ian N Olver and 1 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Long-Term Cognitive Dysfunction in Cancer Survivors.Frontiers in molecular biosciences · 2021
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Hayley S WhitfordUniversity of South Australia Cancer Research Institute, Adelaide, South Australia, Australia.
Pawel KalinowskiCogstate Limited, Melbourne, Victoria, Australia.
Adrian SchembriCogstate Limited, Melbourne, Victoria, Australia.
Peter GrimisonChris O'Brien Lifehouse, Sydney, New South Wales, Australia.
Martin StocklerNHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
Andrew MartinNHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
Guy C TonerPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Ian D DavisMonash University Eastern Health Clinical School, Melbourne, Victoria, Australia.
Paul MaruffCogstate Limited, Melbourne, Victoria, Australia.
Ian N OlverFaculty of Health and Medical Sciences, University of Adelaide, Frome Road, Adelaide, South Australia, 5005, Australia. inolver@gmail.com.ORCID http://orcid.org/0000-0001-5478-1576
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
The University of Sydney · AUChris O’Brien Lifehouse · AUEastern Health · AUPeter MacCallum Cancer Centre · AUThe University of Adelaide · AUUniversity of South Australia · AU

Funding

National Health and Medical Research Council APP1102604
6 · The paper itself

Abstract

purposeThe causal link between chemotherapy and cognitive impairment is unclear. We studied testicular cancer patients' objective and subjective cognitive function longitudinally, comparing a surgery group with a surgery + chemotherapy group, addressing prior methodological issues using a computerized test to limit assessment issues, and controlling for confounding variables.

methodsProspectively, of 145 patients from 16 centres with sufficient data, n = 61 receiving surgery + chemotherapy (etoposide and cisplatin ± bleomycin, BEP/EP; or single agent carboplatin) were compared to n = 41 receiving surgery alone. CogHealth assessed six objective cognitive tasks. The Cognitive Failures Questionnaire assessed self-perceived cognitive dysfunction. The Functional Assessment of Chronic Illness Therapy-Fatigue and the Hospital Anxiety and Depression Scale assessed psychological influences. Linear mixed models compared changes from baseline (< 6 months post-surgery/pre-chemotherapy) to follow-up (12-18 months post-baseline), controlling covariates.

resultsThere were no significant interaction effects for five objective cognitive function tasks suggesting that changes over time were not due to group membership. However, psychomotor function (controlling for age) and physical well-being were significantly worse for the chemotherapy versus the surgery group at baseline, with groups converging by follow-up. Groups showed no differences in subjective cognitive dysfunction. The chemotherapy group showed higher anxiety, poorer functional well-being and worse fatigue compared to the surgery-only group at baseline, but not by follow-up. For both groups, emotional well-being, functional well-being and anxiety significantly improved over time.

conclusionNo substantive differences in objective or subjective cognitive dysfunction in either group persisted 12-18 months post-baseline. Patients undergoing chemotherapy for testicular cancer differ from findings in breast cancer populations.

trial registrationClinicalTrials.gov Identifier: ACTRN12609000545268.

Indexed as

AdultAntineoplastic Combined Chemotherapy ProtocolsBleomycinBreast NeoplasmsCarboplatinCisplatinCognitionCognitive DysfunctionEtoposideFemaleHumansMaleMiddle AgedProspective StudiesTesticular NeoplasmsBleomycinCarboplatinCisplatinEtoposideChemotherapyCognitive functionMoodQuality of lifeSurgeryTesticular cancer

Identifiers

PMID31642990
OpenAlexW2981387579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.